+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Epilepsy Drug"

Neurological Disorder Drugs Market Report 2025 - Product Thumbnail Image

Neurological Disorder Drugs Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
Wilson's Disease Drugs Global Market Report 2025 - Product Thumbnail Image

Wilson's Disease Drugs Global Market Report 2025

  • Report
  • July 2025
  • 175 Pages
  • Global
From
Lennox Gastaut Syndrome Global Market Report 2025 - Product Thumbnail Image

Lennox Gastaut Syndrome Global Market Report 2025

  • Report
  • July 2025
  • 175 Pages
  • Global
From
Adult Intraventricular Hemorrhage Market Report 2025 - Product Thumbnail Image

Adult Intraventricular Hemorrhage Market Report 2025

  • Report
  • April 2025
  • 200 Pages
  • Global
From
From
Dravet Syndrome Market - Global Strategic Business Report - Product Thumbnail Image

Dravet Syndrome Market - Global Strategic Business Report

  • Report
  • February 2026
  • 485 Pages
  • Global
From
Barbiturate Drugs Market - Global Strategic Business Report - Product Thumbnail Image

Barbiturate Drugs Market - Global Strategic Business Report

  • Report
  • February 2026
  • 386 Pages
  • Global
From
Phenobarbital Market - Global Strategic Business Report - Product Thumbnail Image

Phenobarbital Market - Global Strategic Business Report

  • Report
  • February 2026
  • 362 Pages
  • Global
From
Pediatric Epilepsy Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Pediatric Epilepsy Therapeutics - Global Strategic Business Report

  • Report
  • February 2026
  • 184 Pages
  • Global
From
From
Cannabidiol - Global Strategic Business Report - Product Thumbnail Image

Cannabidiol - Global Strategic Business Report

  • Report
  • February 2026
  • 377 Pages
  • Global
From
CNS Therapeutics - Global Strategic Business Report - Product Thumbnail Image

CNS Therapeutics - Global Strategic Business Report

  • Report
  • February 2026
  • 506 Pages
  • Global
From
Status Epilepticus Market Report 2025 - Product Thumbnail Image

Status Epilepticus Market Report 2025

  • Report
  • October 2025
  • 250 Pages
  • Global
From
Grand Mal Seizure Treatment Market Report 2025 - Product Thumbnail Image

Grand Mal Seizure Treatment Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
Generic Central Nervous System Drugs Market Report 2025 - Product Thumbnail Image

Generic Central Nervous System Drugs Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
Epidiolex (Cannabidiol) Market Report 2025 - Product Thumbnail Image

Epidiolex (Cannabidiol) Market Report 2025

  • Report
  • April 2025
  • 175 Pages
  • Global
From
Episodic Ataxia Treatment Market Report 2025 - Product Thumbnail Image

Episodic Ataxia Treatment Market Report 2025

  • Report
  • April 2025
  • 200 Pages
  • Global
From
Cerebral Palsy Treatment Market Report 2025 - Product Thumbnail Image

Cerebral Palsy Treatment Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
GABA A Receptor Agonist - Pipeline Insight, 2025 - Product Thumbnail Image

GABA A Receptor Agonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Loading Indicator

The Epilepsy Drug market is a subset of the Central Nervous System Drugs market, which includes drugs used to treat neurological disorders. Epilepsy drugs are used to treat seizures, which are caused by abnormal electrical activity in the brain. These drugs work by either suppressing the abnormal electrical activity or increasing the amount of neurotransmitters in the brain. Commonly used epilepsy drugs include anticonvulsants, benzodiazepines, and barbiturates. Epilepsy drugs are used to treat a wide range of seizure types, including tonic-clonic seizures, absence seizures, and myoclonic seizures. They are also used to treat other neurological disorders, such as bipolar disorder and anxiety. The market for epilepsy drugs is highly competitive, with many companies offering a variety of products. Some of the major players in the market include Pfizer, GlaxoSmithKline, Novartis, Sanofi, and Johnson & Johnson. Show Less Read more